Hayatbakhsh Mohammad R, Najman Jake M, Jamrozik Konrad, Mamun Abdullah A, Alati Rosa, Bor William
Drs. Hayatbakhsh, Mamun, Alati, Najman, and Jamrozik are with the School of Population Health, University of Queensland, Brisbane, Australia; Dr. Bor is with the Mater Centre for Service Research in Mental Health, Mater Hospital, Brisbane, Australia; and Dr. Najman is also with the School of Social Science, University of Queensland.
Drs. Hayatbakhsh, Mamun, Alati, Najman, and Jamrozik are with the School of Population Health, University of Queensland, Brisbane, Australia; Dr. Bor is with the Mater Centre for Service Research in Mental Health, Mater Hospital, Brisbane, Australia; and Dr. Najman is also with the School of Social Science, University of Queensland.
J Am Acad Child Adolesc Psychiatry. 2007 Mar;46(3):408-417. doi: 10.1097/chi.0b013e31802dc54d.
To examine whether age of first use or frequency of use of cannabis is associated with anxiety and depression (AD) in young adults, independent of known potential confounders, including the use of other illicit drugs.
A cohort of 3,239 Australian young adults was followed from birth to the age of 21 when data on AD were obtained from sample members along with information on their use of cannabis at 21 years. Potential confounding factors were prospectively measured when the child was born and at 14 years.
After controlling for confounding factors, those who started using cannabis before age 15 years and used it frequently at 21 years were more likely to report symptoms of AD in early adulthood (odds ratio 3.4; 95% CI 1.9-6.1). This association was of similar magnitude for those who had only used cannabis and those who reported having used cannabis and other illicit drugs.
The relationship between early-onset and frequent use of cannabis and symptoms of AD is independent of individual and family backgrounds. Frequent cannabis use is associated with increased AD in young adults independently of whether the person also uses other illicit drugs.
探讨首次使用大麻的年龄或使用频率是否与年轻成年人的焦虑和抑郁(AD)相关,且独立于已知的潜在混杂因素,包括其他非法药物的使用情况。
对3239名澳大利亚年轻成年人进行队列研究,从出生开始跟踪至21岁,此时从样本成员处获取有关AD的数据以及他们在21岁时使用大麻的信息。潜在的混杂因素在孩子出生时和14岁时进行前瞻性测量。
在控制混杂因素后,那些在15岁之前开始使用大麻且在21岁时频繁使用大麻的人在成年早期更有可能报告AD症状(优势比3.4;95%置信区间1.9 - 6.1)。对于仅使用过大麻的人和报告同时使用过大麻及其他非法药物的人,这种关联程度相似。
大麻的早发和频繁使用与AD症状之间的关系独立于个人和家庭背景。频繁使用大麻与年轻成年人AD的增加相关,而与该人是否还使用其他非法药物无关。